Abstract
This Frost & Sullivan research service titled European Endometriosis
Therapeutics Market provides an overview of the current treatment options and
includes a detailed analysis of the technological advances in the market. The
study also identifies key market drivers and restraints. In this research,
Frost & Sullivan' s expert analysts thoroughly examine the following markets:
GnRH analogues, progestins and danazols.
This research service is available through our Pharmaceuticals and
Biotechnology Growth Partnership Services program. With this program you
receive industry-leading market research such as this, along with technical
and econometric data and many interactive features including Analyst Inquiry
Time and Client Councils.
View Cart
